67 related articles for article (PubMed ID: 15221651)
1. Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.
Wei JJ; William J; Bulun S
Int J Gynecol Pathol; 2011 Nov; 30(6):553-68. PubMed ID: 21979592
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.
Maeda D; Shih IeM
Adv Anat Pathol; 2013 Jan; 20(1):45-52. PubMed ID: 23232571
[TBL] [Abstract][Full Text] [Related]
3. Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma.
Leenen S; Hermens M; de Vos van Steenwijk PJ; Bekkers RLM; van Esch EMG
Cancer Immunol Immunother; 2021 Jul; 70(7):1821-1829. PubMed ID: 33411080
[TBL] [Abstract][Full Text] [Related]
4. The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis.
Su KM; Lin TW; Liu LC; Yang YP; Wang ML; Tsai PH; Wang PH; Yu MH; Chang CM; Chang CC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316695
[TBL] [Abstract][Full Text] [Related]
5. The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer.
Ou T; Lilly M; Jiang W
Front Immunol; 2018; 9():1188. PubMed ID: 29928275
[TBL] [Abstract][Full Text] [Related]
6. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
7. Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.
Bedaiwy MA; Hussein MR; Biscotti C; Falcone T
Pathol Oncol Res; 2009 Mar; 15(1):81-8. PubMed ID: 18575828
[TBL] [Abstract][Full Text] [Related]
8. Endometriosis and the neoplastic process.
Varma R; Rollason T; Gupta JK; Maher ER
Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma.
Otsuka J; Okuda T; Sekizawa A; Amemiya S; Saito H; Okai T; Kushima M; Tachikawa T
Med Electron Microsc; 2004 Sep; 37(3):188-92. PubMed ID: 15449112
[TBL] [Abstract][Full Text] [Related]
11. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
14. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
